FDA Warns Ferring, Says Firmagon Sales Pitch Is Misleading
Ferring Pharmaceuticals Inc. was hit with a warning letter from the U.S. Food and Drug Administration, posted to the agency's website Friday, for making unsubstantiated claims that its prostate cancer treatment...To view the full article, register now.
Already a subscriber? Click here to view full article